| 000 | 01774cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223032516.0 | ||
| 008 | 200120s2020 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.03.M.Sc.2020.Sa.D | ||
| 100 | 0 | _aSamah Mamdouh Kamal | |
| 245 | 1 | 0 |
_aDevelopment and validation of bioanalytical methods for therapeutic drug monitoring / _cSamah Mamdouh Kamal ; Supervised Badr Eldean Abdelhaleam Elzeany , Medhat Ahmed Alghobashy , Ali Kamal Atia |
| 246 | 1 | 5 | _aالتطوير والتحقق من كفاءة طرق تحليل بيولوجية لتتبع الأدوية العلاجية |
| 260 |
_aCairo : _bSamah Mamdouh Kamal , _c2020 |
||
| 300 |
_a166 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Analytical Chemistry | ||
| 520 | _aThis thesis consists of four main parts: Part I:General introduction on therapeutic drug monitoring, Part II: Determination of voriconazole in presence of co-administered drugs esomeprazole and ondansetron, Part III: Determination of linezolid in presence of co-administered drugs meropenem and theophylline, andfinally Part IV: General discussion in addition to the references and the arabic summary | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aLinezolid | |
| 653 | 4 | _aTherapeutic drug monitoring | |
| 653 | 4 | _aVoriconazole | |
| 700 | 0 |
_aAli Kamal Atia , _eSupervisor |
|
| 700 | 0 |
_aBadr Eldean Abdelhaleam Elzeany , _eSupervisor |
|
| 700 | 0 |
_aMedhat Ahmed Alghobashy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aShimaa _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c76396 _d76396 |
||